Applying Genomic and Proteomic Microarray Technology in Drug by Robert S. Matson

By Robert S. Matson

Microarrays play an more and more major function in drug discovery. Written by means of a pace-setter within the box, employing Genomic and Proteomic Microarray know-how in Drug Discovery highlights, describes, and evaluates present medical examine utilizing microarray expertise in genomic and proteomic functions. the writer addresses the drawbacks, supporting you stay away from pointless pitfalls, and offers functional how you can hire the know-how in drug discovery and improvement. The ebook info the economic panorama, protecting the various concerns surrounding the long run adoption of gene expression and protein microarrays for pharmacogenomic and pharmacoproteomic functions. the writer severely assesses these experiences that experience helped outline functions in genomics and proteomics, explains gene expression microarray purposes, and examines the software of the protein microarray. He covers substitute substrates and the instruction of varied floor chemistries including their suitability for immobilization of nucleic acids and proteins. He delineates the mechanics of microarraying together with environmental stipulations, printer and pin functionality, in addition to dialogue relating to constructing the print run. The ebook provides protocols for printing nucleic acids and proteins and an in-depth dialogue of alternative very important parameters equivalent to print buffers (inks) and components influencing print caliber. An realizing of the making of a microarray is essentially vital to these drawn to generating "spotted" arrays and their right use. As this know-how expands in acceptance and value, specialists needs to clutch the elemental ideas at the back of it, its strengths, and its boundaries. A uncomplicated reference for clients of microarray expertise in drug discovery, this publication bargains an in depth point of view and perception into the current and destiny makes use of of this expertise.

Show description

Read or Download Applying Genomic and Proteomic Microarray Technology in Drug Discovery PDF

Best bioinformatics books

Microarrays for an Integrative Genomics

Sensible genomics--the deconstruction of the genome to figure out the organic functionality of genes and gene interactions--is essentially the most fruitful new parts of biology. The transforming into use of DNA microarrays permits researchers to evaluate the expression of tens of hundreds of thousands of genes at a time. This quantitative swap has ended in qualitative development in our skill to appreciate regulatory approaches on the mobile point.

DNA Topoisomerase Protocols Volume 1: DNA Topology and Enzymes (Methods in Molecular Biology Vol 94)

Starting with the Escherichia coli co protein, or bacterial DNA topoisomerase I, an ever-increasing variety of enzymes has been pointed out that catalyze alterations within the linkage of DNA strands. DNA topoisomerases are ubiquitous in nature and feature been proven to play severe roles in such a lot p- cesses related to DNA, together with DNA replication, transcription, and rec- bination.

The Promise of Neural Networks

This publication is the made of a 15-month in depth research of the eu man made community scene, including a view of the wider framework of the topic in an international context. it might probably no longer were accomplished in one of these remarkably little while, and so successfully, with out the committed efforts of Louise Turner, the DEANNA secretary, and Geoff Chappell, the DEANNA researcher, on the Centre for Neural Networks, King's collage, London.

Additional resources for Applying Genomic and Proteomic Microarray Technology in Drug Discovery

Sample text

Oligonucleotides in the range of 24 to 90-mer are synthesized with good stepwise yields. In order to accommodate current scanner resolution, the densities have been reduced. Two formats covering the area of a standard slide are provided: 195,000 probes (1:4) and 390,000 probes (1:2). A 24-mer array can be synthesized within 2 to 4 hr. 5%. ” The product is a fully integrated instrument providing for DNA design, synthesis, hybridization, and analysis. 5). Each microarray is produced with up to 6000 features (34 µm2 each) or about 48,000 probes per disposable DNA processor.

Biol. , 276, 45497–45500, 2001. , Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions, Genome Biol. 13, 2001. , Disease proteomics, Nature, 422, 226–232, 2003. , Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells, Mol. , 1, 300–311, 2003. , 62, 2806–2812, 2002. , 4, 290–295, 2002. , The impact of protein biochips and microarrays on the drug development process, Drug Discovery Today, 7, S119–S124, 2002.

They were able to produce in situ oligonucleotide arrays of 76,800 features (16 µm2) on standard microscope slides with a stepwise yield of about 95% for 18-mer in 12 hr. 3-cm2 area on a slide. Oligonucleotides in the range of 24 to 90-mer are synthesized with good stepwise yields. In order to accommodate current scanner resolution, the densities have been reduced. Two formats covering the area of a standard slide are provided: 195,000 probes (1:4) and 390,000 probes (1:2). A 24-mer array can be synthesized within 2 to 4 hr.

Download PDF sample

Rated 4.21 of 5 – based on 9 votes